ACUTE RHEUMATIC FEVER

Feigin and Cherry's Textbook of Pediatric Infectious Diseases, Sixth Edition

Volumn , Issue , 2009, Pages 419-434

  Lennon, Diana R ^a,b  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b STARSHIP CHILDREN S HOSPITAL   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 74049145264     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-4160-4044-6.50040-6     Document Type: Chapter

References (227)

1. M. Abernethy, N. Bass, N. Sharpe, et al. (1994) Doppler echocardiography and the early diagnosis of carditis in acute rheumatic fever. Aust. N. Z. J. Med. 24 530-535.
2. B.L. Agarwal (1988) Rheumatic Fever and Rheumatic Heart Disease in Developing Countries India: Arnold Publishers
3. P.K. Agarwal, M. Misra, et al. (1998) Usefulness of echocardiography in detection of subclinical carditis in acute rheumatic polyarthritis and rheumatic chorea. J. Assoc. Physicians India 46 937-938.
4. A. al-Eissa (1993) Sydenham's chorea: A new look at an old disease. Br. J. Clin. Pract. 47 14-16.
5. S. Al Kasab, M. Al Fabih, et al. (1988) Valve surgery in acute rheumatic heart disease: One-to four-year follow-up. Chest 94 830-833.
6. D.A. Albert, L. Harel, et al. (1995) The treatment of rheumatic carditis: A review and meta-analysis. Medicine 74 1-12.
7. J. Amir, S. Ginat, Y.H. Cohen, et al. (1998) Lidocaine as a diluent for administration of benzathine penicillin G. Pediatr. Infect. Dis. J. 17 890-893.
8. Anonymous (1965) The natural history of rheumatic fever and rheumatic heart disease: Ten year report of a cooperative clinical trial of ACTH, cortisone and aspirin. Circulation 32 457-476.
9. Anonymous (1965) Treatment of rheumatic fever (editorial). N. Engl. J. Med. 272 101-102.
10. Anonymous (1982) Prevention of rheumatic heart disease. Lancet 143-144.
11. Anonymous (1988) Acute rheumatic fever among army trainees—Fort Leonard Wood, Missouri 1987-1988. M. M. W. R. Morb. Mortal. Wkly. Rep. 37 519-522.
12. Anonymous (1992) Availability of sulfadiazine—United States. M. M. W. R. Morb. Mortal. Wkly. Rep. 41 950-951.
13. M.J. Antunes (1990) Mitral valvuloplasty, a better alternative: Comparative study between valve reconstruction and replacement for rheumatic mitral valve disease. Eur. J. Cardiothorac. Surg. 4 257-264.
14. A.M. Aron, J.M. Freeman, et al. (1965) The natural history of Sydenham's chorea. Am. J. Med. 38 83-95.
15. M. Atha, E. Enos, et al. (1982) How an American Indian tribe controlled the streptococcus. World Health Forum 3 423-428.
16. E.M. Ayoub and H.A. Majeed (2000) Poststreptococcal reactive arthritis. Curr. Opin. Rheumatol. 12 306-310.
17. R.W. Baird, M.S. Bronze, et al. (1991) Epitopes of group A streptococcal M protein shared with antigens of articular cartilage and synovium. J. Immunol. 146 3132-3137.
18. J.B. Barlow (1992) Aspects of active rheumatic carditis. Aust. N. Z. J. Med. 22 592-600.
19. J.W. Bass, F.W. Crast, et al. (1976) Streptococcal pharyngitis in children: A comparison of four treatment schedules with intramuscular penicillin G benzathine. J. A. M. A. 235 1112-1116.
20. E.H. Beachey, M. Bronze, et al. (1988) Protective and autoimmune epitopes of streptococcal M proteins. Vaccine 6 192-196.
21. E.H. Beachey, G.H. Stollerman, et al. (1979) Human immune response to immunization with a structurally defined polypeptide fragment of streptococcal M protein. J. Exp. Med. 150 862-877.
22. X. Berrios, E. del Campo, et al. (1993) Discontinuing rheumatic fever prophylaxis in selected adolescents and young adults. Ann. Intern. Med. 118 401-406.
23. X. Berrios, F. Quesney, et al. (1985) Are all recurrences of “pure” Sydenham chorea true recurrences of acute rheumatic fever. J. Pediatr. 107 867-872.
24. D.E. Bessen, C.M. Sotir, et al. (1996) Genetic correlates of throat and skin isolates of group A streptococci. J. Infect. Dis. 173 896-900.
25. A. Bisno (1980) The concept of rheumatogenic and nephritogenic group A streptococci. S.E. Read, J.B. Zabriskie (Eds) Streptococal Diseases and the Immune Response New York: Academic Press 789-804.
26. A. Bisno (1991) Group A streptococcal infections and acute rheumatic fever. N. Engl. J. Med. 325 783-793.
27. A. Bisno, M. Brito, et al. (2003) Molecular basis of group A streptococcal virulence. Lancet Infect. Dis. 3 191-200.
28. A. Bisno and M. Land (1984) Incidence of acute rheumatic fever in Memphis and Shelby County, Tennessee, 1977-1981. A. Shulman (Eds) Management of Pharngitis in an Era of Declining Rheumatic Fever Columbus, OH: Ross Laboratories 13-24.
29. A. Bisno, I. Pearce, et al. (1977) Streptococcal infections that fail to cause recurrences of rheumatic fever. J. Infect. Dis. 136 278-285.
30. A.L. Bisno, M.O. Brito, et al. (2003) Molecular basis of group A streptococcal virulence. Lancet Infect. Dis. 3 191-200.
31. A.L. Bisno, M.A. Gerber, et al. (2002) Practice guidelines for the diagnosis and management of group A streptococcal pharyngitis. Infectious Diseases Society of America. Clin. Infect. Dis. 35 113-125.
32. A.L. Bisno, I.A. Pearce, et al. (1970) Contrasting epidemiology of acute rheumatic fever and acute glomerulonephritis. N. Engl. J. Med. 283 561-565.
33. A.L. Bisno, F.A. Rubin, P.P. Cleary, et al. (2005) Prospect for a group A streptococcal vaccine: Rationale, feasibility, and obstacles—report of a National Institute of Allergy and Infectious Diseases workshop. Clin. Infect. Dis. 41 1150-1156.
34. E.F. Bland and T.D. Jones (1951) Rheumatic fever and rheumatic heart disease: A twenty year report on 1000 patients followed since childhood. Circulation 4 836-843.
35. L.J. Brant, T.R. Bender, et al. (1986) Evaluation of an Alaskan streptococcal control program: Importance of the program's intensity and duration. Prev. Med. 15 632-642.
36. M.S. Bronze, E.H. Beachey, et al. (1988) Protective and heart-crossreactive epitopes located within the NH 2 terminus of type 19 streptococcal M protein. J. Exp. Med. 167 1849-1859.
37. K. Brownell and F. Bailen-Rose (1973) Acute rheumatic fever in children. J. A. M. A. 224 1593-1597.
38. L.M. Cairns (1988) Immunological studies in rheumatic fever: The immunology of rheumatic fever. N. Engl. J. Med. 101 388-391.
39. J. Carapetis and B. Currie (1999) Rheumatic chorea in Northern Australia: A clinical and epidemiological study. Arch. Dis. Child. 80 353-358.
40. J. Carapetis and B. Currie (2001) Rheumatic fever in a high incidence population: The importance of monoarthritis and low grade fever. Arch. Dis. Child. 223-227.
41. J. Carapetis, D. Wolff, et al. (1996) Acute rheumatic fever and rheumatic heart disease in the Top End of Australia's Northern Territory. Med. J. Aust. 164 146-149.
42. F. Cardoso (2004) Chorea: Non-genetic causes. Curr. Opin. Neurol. 17 433-436.
43. F. Catanzaro, C. Rammelkamp, et al. (1958) Prevention of rheumatic fever by treatment of streptococcal infections, II: Factors responsible for failures. N. Engl. J. Med. 259 51-57.
44. F.J. Catanzaro, C.A. Jetson, et al. (1954) The role of the streptococcus in the pathogenesis of rheumatic fever. Am. J. Med. 17 749-756.
45. R.M. Centor, J.M. Witherspoon, H.P. Dalton, et al. (1981) The diagnosis of strep throat in adults in the emergency room. Med. Decis. Making 1 239-246.
46. S. Chauvaud, P. Perier, et al. (1986) Long-term results of valve repair in children with acquired mitral valve imcompetence. Circulation 74(Suppl.), 104-109.
47. L.T. Chun, D.V. Reddy, et al. (1984) Occurrence and prevention of rheumatic fever among ethnic groups of Hawaii. Am. J. Dis. Child. 138 476-478.
48. L.T. Chun, D.V. Reddy, et al. (1987) Rheumatic fever in children and adolescents in Hawaii. Pediatrics 79 549-552.
49. A.M. Cilliers, J. Manyemba and H. Saloojee (2003) Anti-inflammatory treatment for carditis in acute rheumatic fever (review). Cochrane Database Syst. Rev. 3 CD003176
50. H.W. Clegg, A.G. Ryan, S.D. Dallas, et al. (2006) Treatment of streptococcal pharyngitis with once-daily compared with twice-daily amoxicillin: A noninferiority trial. Pediatr. Infect. Dis. J. 25 761-767.
51. Combined Rheumatic Fever Study Group (1965) A comparison of short-term, intensive prednisone and acetylsalicylic acid therapy in the treatment of acute rheumatic fever. N. Engl. J. Med. 272 63-70.
52. Committee on Infectious Diseases, American Academy of Pediatrics (2006) Red Book: 2006 Report of the Committee on Infectious Diseases Elk Grove, IL: American Academy of Pediatrics
53. B. Congeni, C. Rizzo, et al. (1987) Outbreak of acute rheumatic fever in northeast Ohio. J. Pediatr. 111 176-179.
54. J. Coulehan, S. Grant, et al. (1980) Acute rheumatic fever and rheumatic heart disease on the Navajo Reservation, 1962-77. Public Health Rep. 95 62-68.
55. M. Cunningham (2000) Pathogenesis of group A streptococcal infections. Clin. Microbiol. Rev. 13 470-511.
56. M. Cunningham and M. Russell (1983) Study of heart-reactive antibody in antisera and hybridoma culture fluids against group A streptococci. Infect. Immunity 42 531-538.
57. B.J. Currie (2006) Group A streptococcal infections of the skin: Molecular advances but limited therapeutic progress. Curr. Opin. Infect. Dis. 19 132-138.
58. A. Dajani, A. Bisno, et al. (1990) Prevention of bacterial endocarditis: Recommendations by the American Heart Association. J. A. M. A. 264 2919-2922.
59. A. Dajani, K. Taubert, et al. (1995) Treatment of acute streptococcal pharyngitis and prevention of rheumatic fever: A statement for health professionals. Pediatrics 96 758-764.
60. A.S. Dajani, K. Taubert, et al. (1995) Treatment of acute streptococcal pharyngitis and prevention of rheumatic fever: A statement for health professionals. Pediatrics 96 758-764.
61. A.S. Dajani, K.A. Taubert, et al. (1997) Prevention of bacterial endocarditis: Recommendations by the American Heart Association. J. A. M. A. 277 1794-1801.
62. J.B. Dale and E.H. Beachey (1982) Protective antigenic determinant of streptococcal M protein shared with sarcolemmal membrane protein in human heart. J. Exp. Med. 156 1165-1176.
63. J.B. Dale and E.H. Beachey (1985) Epitopes of streptococcal M proteins shared with cardiac myosin. J. Exp. Med. 162 583-591.
64. J.B. Dale and E.H. Beachey (1987) Human cytotoxic T lymphocytes evoked by group A streptococcal M proteins. J. Exp. Med. 166 1825-1937.
65. A.S. Daoud, M. Zaki, et al. (1990) Effectiveness of sodium valproate in the treatment of Sydenham's chorea. Neurology 40 1140-1141.
66. C.L. De Cunto, E.H. Giannini, C.W. Fink, et al. (1988) Prognosis of children with poststreptococcal reactive arthritis. Pediatr. Infect. Dis. J. 7 683-686.
67. F. Denny, L. Wannamaker, et al. (1950) Prevention of rheumatic fever: Treatment of the preceding streptococcic infection. J. A. M. A. 143 151-153.
68. F.W. Denny (1994) A 45-year perspective on the streptococcus and rheumatic fever: The Edward H. Kass lecture in infectious disease history. Clin. Infect. Dis. 19 1110-1122.
69. J.M. Eckerd and J.E. McJunkin (1989) Recent increase in incidence of acute rheumatic fever in southern West Virginia. W. Va. Med. J. 85 323-325.
70. H.M. Feder, M.A. Gerber, et al. (1999) Once-daily therapy for streptococcal pharyngitis with amoxycillin. Pediatrics 103 47-51.
71. A.R. Feinstein and M. Spagnuolo (1960) Mimetic features of rheumatic fever recurrences. N. Engl. J. Med. 262 533-540.
72. B.M. Feldman, J.B. Zabriskie, et al. (1993) Diagnostic use of B-cell alloantigen D8/17 in rheumatic chorea. J. Pediatr. 123 84-86.
73. G.W. Ferguson, J.M. Shultz, et al. (1991) Epidemiology of acute rheumatic fever in a multiethnic, multiracial urban community: The Miami-Dade County experience. J. Infect. Dis. 164 720-725.
74. P. Ferrieri, Jones Criteria Working Group (2002) Proceedings of the Jones Criteria workshop. Circulation 106 2521-2523.
75. F.E. Figueroa, M.S. Fernandez, et al. (2001) Prospective comparison of clinical and echocardiographic diagnosis of rheumatic carditis: Long term follow up of patients with subclinical disease. Heart 85 407-410.
76. G.M. Folger, R. Hajar, et al. (1992) Occurrence of valvular heart disease in acute rheumatic fever without evident carditis: Colour flow Doppler identification. Br. Heart J. 67 434-438.
77. G.M. Folger, R. Hajar, et al. (1989) Doppler echocardiographic findings of mitral and aortic valve regurgitation in children manifesting only rheumatic arthritis. Am. J. Cardiol. 63 1278-1280.
78. J.D. Frankish (1984) Rheumatic fever prophylaxis: Gisborne experience. N. Z. Med. J. 97 674-675.
79. F. Genel, S. Arslanoglu, et al. (2002) Sydenham's chorea: Clinical findings and comparison of the efficacies of sodium valproate and carbamazepine regimens. Brain Dev. 24 73-76.
80. T.L. Gentles, S.D. Colan, et al. (2001) Left ventricular mechanics during and after acute rheumatic fever: Contractile dysfunction is closely related to valve regurgitation. J. Am. Coll. Cardiol. 37 201-207.
81. M.A. Gerber, M.F. Randolph, et al. (1986) Antigen detection test for streptococcal pharyngitis: Evaluation of sensitivity with respect to true infections. J. Pediatr. 108 654-658.
82. M.A. Gerber and S.T. Shulman (2004) Rapid diagnosis of pharyngitis caused by group A streptococci. Clin. Microbiol. Rev. 17 571-580.
83. A. Gibofsky and J. Zabrigkie (1994) Rheumatic fever: New insights into an old disease. Bull. Rheum. Dis. 42 5-7.
84. I. Goldstein, B. Halpern, et al. (1967) Immunological relationship between streptococcus A polysaccharide and the structural glycoproteins of heart value. Nature 213 44-47.
85. L. Gordis (1973) Effectiveness of comprehensive-care programs in preventing rheumatic fever. N. Engl. J. Med. 289 331-335.
86. L. Gordis, A. Lilienfeld, et al. (1969) A community-wide study of acute rheumatic fever in adults: Epidemiologic and preventive factors. J. A. M. A. 210 862-865.
87. L. Gordis, A. Lilienfeld, et al. (1969) Studies in the epidemiology and preventability of rheumatic fever. II: Socio-economic factors and the incidence of acute attacks. J. Chron. Dis. 21 645-654.
88. L. Gordis, A. Lilienfeld, et al. (1969) Studies in the epidemiology and preventability of rheumatic fever. II: Socio-economic factors and the incidence of acute attacks. J. Chron. Dis. 21 655-666.
89. E.D. Gray, W.E. Regelmann, et al. (1987) Compartmentalisation of cells bearing “rheumatic” cell surface antigens in peripheral blood and tonsils in rheumatic heart disease. J. Infect. Dis. 155 247-252.
90. S. Grayson, M. Horsburgh, et al. (2006) An Auckland regional audit of the nurse-led rheumatic fever secondary prophylaxis programme. N. Z. Med. J. 119 U2255.
91. S.P. Griffiths and W.M. Gersony (1990) Acute rheumatic fever in New York City (1969-1988): A comparative study of two decades. J. Pediatr. 116 882-887.
92. G.A. Harlan, L.Y. Tani, et al. (2006) Rheumatic fever presenting as monoarticular arthritis. Pediatr. Infect. Dis. J. 25 743-746.
93. Z. Harrington, K. Visvanathan, et al. (2006) B-cell antigen D8/17 is a marker of rheumatic fever susceptibility in Aboriginal Australians and can be tested in remote settings. Med. J. Aust. 184 507-510.
94. P.J. Hashkes, T. Tauber, et al. (2003) Naproxen as an alternative to aspirin for the treatment of arthritis of rheumatic fever: A randomized trial. J. Pediatr. 143 399-401.
95. C. Homer and S. Shulman (1991) Clinical aspects of acute rheumatic fever. J. Rheumatol. 18 2-13.
96. D. Hosier, J. Craenen, et al. (1987) Resurgence of acute rheumatic fever. Am. J. Dis. Child. 141 730-733.
97. International Rheumatic Fever Study Group (1991) Allergic reactions to long-term benzathine penicillin prophylaxis for rheumatic fever. Lancet 337 1308-1310.
98. E. Kaplan (1978) Acute rheumatic fever. Pediatr. Clin. North Am. 25 817-829.
99. E. Kaplan, X. Berrios, et al. (1989) Pharmacokinetics of benzathine penicillin G: Serum levels during the 28 days after intramuscular injection of 1,200,000 units. J. Pediatr. 115 146-151.
100. E. Kaplan, D. Johnson, et al. (1989) Group A streptococcal serotypes isolated from patients and sibling contacts during the resurgence of rheumatic fever in the United States in the mid-1980s. J. Infect. Dis. 159 101-103.
101. E. Kaplan, C. Rothermel, et al. (1998) Antistreptolysin O and anti-deoxyribonuclease B titers: Normal values for children ages 2 to 12 in the United States. Pediatrics 101 86-88.
102. E. Kaplan, F. Top, et al. (1971) Diagnosis of streptococcal pharyngitis: Differentiation of active infection from the carrier state in the symptomatic child. J. Infect. Dis. 123 490-501.
103. E. Kaplan and L. Wannamaker (1974) Streptolysin O: Suppression of its antigenicity by lipids extracted from skin. Proc. Soc. Exp. Biol. Med. 146 205-208.
104. E.L. Kaplan and A.L. Bisno (2006) Antecedent streptococcal infection in acute rheumatic fever. Clin. Infect. Dis. 43 690-692.
105. M. Kaplan, R. Bolande, et al. (1964) Presence of bound immunoglobulins and complement in the myocardium in acute rheumatic fever: Association with cardiac failure. N. Engl. J. Med. 271 637-645.
106. A.S. Kassem, S.R. Zaher, et al. (1996) Rheumatic fever prophylaxis using benzathine penicillin G (BPG): Two-week versus four-week regimens: Comparison of two brands of BPG. Pediatrics 97(Pt. 2), 925-992.
107. I. Khriesat and A.H. Najada (2003) Acute rheumatic fever without early carditis: An atypical clinical presentation. Eur. J. Pediatr. 162 868-871.
108. R. Kumar (1995) Controlling rheumatic heart disease in developing countries. World Health Forum 16 47-51.
109. R. Kurlan and E.L. Kaplan (2004) The pediatric autoimmune neuropsychiatric disorders associated with streptococcal infection (PANDAS) etiology for tics and obsessive-compulsive symptoms: Hypothesis or entity?. Practical considerations for the clinician. Pediatrics 113 883-886.
110. O. Laitinen, M. Leirisalo, et al. (1975) Rheumatic fever and Yersinia arthritis criteria and diagnostic problems in a changing disease pattern. Scand. J. Rheumatol. 4 145-157.
111. R.C. Lancefield (1962) Current knowledge of type-specific Mantigens of group A streptococci. J. Immunol. 89 307-313.
112. M. Land and A. Bisno (1983) Acute rheumatic fever: A vanishing disease in suburbia. J. A. M. A. 249 895-898.
113. R. Leggiadro, S. Birnbaum, et al. (1990) A resurgence of acute rheumatic fever in a mid-South children's hospital. South. Med. J. 83 1418-1420.
114. D. Lennon (2004) Acute rheumatic fever in children: Recognition and treatment. Pediatr. Drugs 6 363-373.
115. D. Lennon, B. Arroll, et al. (2007) Meta analysis of streptococcal throat treatment trials to prevent rheumatic fever primarily in a school-based setting supports this intervention for the control of acute rheumatic fever. Lancet
116. Lennon, D., Farrell, E., et al.: Once-daily amoxicillin versus twice-daily penicillin V in group A β-hemolytic streptococcal pharyngitis. 2006.
117. D. Lennon, D. Martin, et al. (1988) Longitudinal study of poststreptococcal disease in Auckland: Rheumatic fever, glomerulonephritis, epidemiology and M typing 1981-86. N. Z. Med. J. 101(Pt. 2), 396-398.
118. Lennon, D., Stewart, J., et al.: A RCT of a school-based primary prevention programme for rheumatic fever. 2007.
119. Lennon, D., Wilson, N., et al.: New Zealand guidelines for rheumatic fever, 1: Diagnosis, management and secondary prophylaxis. 2006.
120. Lennon, D., Wilson, N., et al.: New Zealand guidelines for rheumatic fever, 2: Sore throat management. 2006.
121. H. Lue, M. Wu, et al. (1994) Long-term outcome of patients with rheumatic fever receiving benzathine penicillin G prophylaxis every three weeks versus every four weeks. J. Pediatr. 125(Pt. 1), 812-817.
122. H.C. Lue, M.H. Wu, et al. (1996) Three-versus four-week administration of benzathine penicillin G: Effects on incidence of streptococcal infections and recurrences of rheumatic fever. Pediatrics 97(Pt. 2), 984-988.
123. H. Majeed, A. Yousof, et al. (1986) The natural history of acute rheumatic fever in Kuwait: A prospective 6-year follow-up report. J. Chron. Dis. 39 361-369.
124. H. Majeed, A. Yousof, et al. (1992) Group A streptococcal strains in Kuwait: A nine-year prospective study of prevalence and associations. Pediatr. Infect. Dis. J. 11 295-300.
125. J. Manyemba and B.M. Mayosi (2002) Penicillin for secondary prevention of rheumatic fever. Cochrane Database Syst. Rev. 3 CD002227.
126. E. Marijon, P. Ou, D.S. Celermajer, et al. (2007) Prevalence of rheumatic heart disease detected by echocardiographic screening. N. Engl. J. Med. 357 470-476.
127. M. Markowitz (1988) Evolution and critique of changes in the Jones Criteria for diagnosis of rheumatic fever. N. Z. Med. J. 101 392-394.
128. M. Markowitz (1991) Streptococcal disease in developing countries. Pediatr. Infect. Dis. J. 10 S11-S38.
129. M. Markowitz and L. Gordis (1972) Rheumatic Fever Philadelphia: W. B. Saunders
130. M. Markowitz and E. Kaplan (1989) Reappearance of rheumatic fever. Adv. Pediatr. 36 39-68.
131. P. Marrack and J. Kappler (1990) The staphylococcal enterotoxins and their relatives. Science 248 705-711.
132. D. Martin and L. Single (1993) Molecular epidemiology of group A streptococcus M type 1 infections. J. Infect. Dis. 167 1112-1117.
133. D.R. Martin, L.M. Voss, et al. (1994) Acute rheumatic fever in Auckland, New Zealand: Spectrum of associated group A streptococci different from expected. Pediatr. Infect. Dis. J. 13 264-269.
134. T.B. Martins, L.G. Veasy, et al. (2006) Antibody responses to group A streptococcal infections in acute rheumatic fever. Pediatr. Infect. Dis. J. 25 832-837.
135. B. Massell, F. Amezcuac, et al. (1964) Evolving picture of rheumatic fever: Data from 40 years at the House of the Good Samaritan. J. A. M. A. 188 287-294.
136. B. Massell, C. Chute, et al. (1988) Penicillin and the marked decrease in morbidity and mortality from rheumatic fever in the United States. N. Engl. J. Med. 318 280-286.
137. B.F. Massell, L.H. Honikman, et al. (1969) Rheumatic fever following streptococcal vaccination: Report of three cases. J. A. M. A. 207 1115-1119.
138. W.J. McIsaac, V. Goel, et al. (1997) Reconsidering sore throats, Part 2: Alternative approach and practical office tool. Can. Fam. Physician 43 495-500.
139. W.J. McIsaac, J.D. Kellner, et al. (2004) Empirical validation of guidelines for the management of pharyngitis in children and adults. J. A. M. A. 291 1587-1595.
140. M.J. McLaren, D.M. Hawkins, et al. (1975) Epidemiology of rheumatic heart disease in black schoolchildren of Soweto, Johannesburg. B. M. J. 3 474-478.
141. S.A. McNeil, S.A. Halperin, et al. (2005) Safety and immunogenicity of 26-valent group A streptococcus vaccine in healthy adult volunteers. Clin. Infect. Dis. 41 1114-1122.
142. C.Y. Miyake, K. Gauvreau, L.Y. Tani, et al. (2007) Characteristics of children discharged from hospitals in the United States in 2000 with the diagnosis of acute rheumatic fever. Pediatrics 120 503-508.
143. D. Moore (1996) Neuropsychiatric aspects of Sydenham's chorea: A comprehensive review. J. Clin. Psychiatry 57 407-414.
144. P. Moore and T. Mortland (1994) Mycoplasma pneumoniae infection mimicking acute rheumatic fever. Pediatr. Infect. Dis. J. 13 81-82.
145. K. Morris, C. Mohan, et al. (1993) Increased inactivated T cells and reduction in suppressor/cytotoxic T cells in acute rheumatic fever and active heart disease: A longitudinal study. J. Infect. Dis. 167 3979-3983.
146. K. Morris, C. Mohan, et al. (1993) Enhancement of IL-1, IL-2, production and IL-2 receptor generation in patients with acute rheumatic fever and active rheumatic heart disease: A prospective study. Clin. Exp. Immunol. 91 429-436.
147. W. Morton, L. Huhn, et al. (1967) Rheumatic heart disease epidemiology: Observations on 17,366 Denver schoolchildren. J. A. M. A. 199 879-884.
148. J. Narula, P. Chopra, et al. (1993) Does endomyocardial biopsy aid in the diagnosis of active rheumatic carditis? Circulation 88(Pt. 1), 2198-2205.
149. P. Nausieda, B. Grossman, et al. (1980) Sydenham chorea: An update. Neurology 30 331-334.
150. J. Newman, D. Lennon, et al. (1984) Patients with rheumatic fever recurrences. N. Z. Med. J. 97 678-680.
151. P. Nordet (1993) WHO/ISFC global programme for the prevention and control of RH/RHD. J. Infect. Cardiol. 3 4-5.
152. S. Padmavati (2001) Rheumatic heart disease: Prevalence and preventive measures in the Indian Subcontinent (editorial). Heart J. 86 127.
153. M.E. Patarroyo, R.J. Winchester, et al. (1979) Association of a B-cell alloantigen with susceptibility to rheumatic fever. Nature 278 173-174.
154. J.R. Paul (1957) Epidemiology of Rheumatic Fever New York: American Heart Association
155. J.A. Paz, C.A.A. Silva, et al. (2006) Randomized double-blind study with prednisone in Sydenham's chorea. Pediatr. Neurol. 34 264-269.
156. J. Pena, E. Mora, et al. (2002) Comparison of the efficacy of carbamazepine, haloperidol and valproic acid in the treatment of children with Sydenham's chorea: Clinical follow-up of 18 patients. Arq. Neuro-Psiquiatr. 60(2B), 374-377.
157. C. Perry and J. Roberts (1937) A study on the variability in the incidence of rheumatic heart disease within the city of Bristol. B. M. J. 154-158.
158. B. Phibbs (1975) Streptococcal control in school children: Is it worthwhile? Minn. Med. 607-610.
159. B. Phibbs, S. Lundin, et al. (1988) Experience of a Wyoming County Streptococcal Control Project. West. J. Med. 148 546-550.
160. W. Pickles (1943) A rheumatic family. Lancet 2 241.
161. G.C.S. Pileggi and P.L. Ferriani (2000) Atypical arthritis in children with rheumatic fever. J. Pediatr. 76 49-54.
162. R. Pinals (1994) Polyarthritis and fever. N. Engl. J. Med. 330 769-774.
163. S.M. Polly, R.H. Waldman, et al. (1975) Protective studies with a group A streptococcal M protein vaccine, II: Challange of volunteers after local immunization in the upper respiratory tract. J. Infect. Dis. 131 217-224.
164. S. Pruksakorn, B. Currie, et al. (1994) Towards a vaccine for rheumatic fever: Identification of a conserved target epitope on M protein of group A streptococci. Lancet 344 639-642.
165. S. Pruksakorn, N. Sittisombut, et al. (2000) Epidemiological analysis of non-M-typeable group A streptococcus isolates from a Thai population in Northern Thailand. J. Clin. Microbiol. 38 1250-1254.
166. R. Quinn and C. Federspiel (1974) The incidence of rheumatic fever in metropolitan Nashville, 1963-1969. Am. J. Epidemiol 99 273-280.
167. V. Raizada, R. Williams, et al. (1983) Tissue distribution of lymphocytes in rheumatic heart valves as defined by monoclonal anti-T cell antibodies. Am. J. Med. 74 90-96.
168. C. Rammelkamp and B. Stolzer (1961) The latent period before the onset of acute rheumatic fever. Yale J. Biol. Med. 34 386-398.
169. C. Rammelkamp, W. Wannamaker, et al. (1972) Studies on the epidemiology of rheumatic fever in the armed services. L. Thomas (Eds) Rheumatic Fever Minneapolis: University of Minnesota Press 72.
170. M. Randolph, M. Gerber, et al. (1985) Effect of antibiotic therapy on the clinical course of streptococcal pharyngitis. J. Pediatr. 106 870-875.
171. D. Reddy, L. Chun, et al. (1989) Acute rheumatic fever with advanced degree AV block. Clin. Pediatr. 28 326-328.
172. W. Regelmann, R. Talbot, et al. (1989) Distribution of cells bearing “rheumatic” antigens in peripheral blood of patients with rheumatic fever/rheumatic heart disease. J. Rheumatol. 16 931-935.
173. P. Atatoa-Carr, D. Lennon and N. Wilson (2008) Rheumatic fever diagnosis, management, and secondary prevention: A New Zealand guideline. N. Z. Med. J. 121 59-69.
174. P. Rhodes and H. Jackson (1975) Rheumatic fever in Colorado: A conquered disease? J. A. M. A. 234 157-158.
175. S.L. Robbins (1994) The Heart: Rheumatic Fever and Rheumatic Heart Disease Philadelphia: W. B. Saunders
176. K.A. Robertson, J.A. Volmink, et al. (2005) Antibiotics for the primary prevention of acute rheumatic fever: a meta-analysis. B. M. C. Cardiovasc. Disord. 5 1-9.
177. S. Sanyal, A. Berry, et al. (1982) Sequelae of the initial attack of acute rheumatic fever in children from North India: A prospective 5 year follow-up study. Circulation 65 375-379.
178. S. Sanyal, M. Thapar, et al. (1974) The initial attack of acute rheumatic fever during childhood in North India: A prospective study of the clinical profile. Circulation 69 7-12.
179. A. Shet and E.L. Kaplan (2002) Clinical use and interpretation of group A streptococcal antibody tests: A practical approach for the pediatrician or primary care physician. Pediatr. Infect. Dis. J. 21 420-426. quiz 427-430
180. S. Shulman (1984) The decline of rheumatic fever: What impact on our management of pharyngitis? Am. J. Dis. Child. 138 426-427.
181. P. Shvartzman, H. Tabenkin, et al. (1993) Treatment of streptococcal pharyngitis with amoxycillin once a day. B. M. J. 306 1170-1172.
182. A. Siegel, E. Johnson, et al. (1961) Controlled studies of streptococcal pharyngitis in a pediatric population. N. Engl. J. Med. 265 559-566.
183. J.C. Smoot, K.D. Barbian, et al. (2002) Genome sequence and comparative microarray analysis of serotype M18 group A streptococcus strains associated with acute rheumatic fever outbreaks. Proc. Natl. Acad. Sci. U. S. A. 99 4668-4673.
184. J.C. Smoot, E.K. Korgenski, et al. (2002) Molecular analysis of group A streptococcus type M18 isolates temporally associated with acute rheumatic fever outbreaks in Salt Lake City, Utah. J. Clin. Microbiol. 40 1805-1810.
185. M. Spagnuolo and A. Taranta (1968) Rheumatic fever in siblings: Similarity of its clinical manifestations. N. Engl. J. Med. 278 183-188.
186. Special Writing Group of the Committee on Rheumatic Fever and Kawasaki Disease of the Council on Cardiovascular Disease in the Young of the American Heart Foundation (1992) Guideline for the diagnosis of rheumatic fever: Jones Criteria 1992 update. J. A. M. A. 268 2069-2073.
187. H. Spinetto, D. Lennon, et al. (2007) Control of rheumatic fever recurrences in Auckland New Zealand: Questions answered
188. G. Stollerman (1991) Rheumatogenic streptococci and autoimmunity. Clin. Immunol. Immunopathol. 61 131-142.
189. G. Stollerman, A. Lewis, et al. (1956) Relationship of immune response to group A streptococci to the course of acute chronic and recurrent rheumatic fever. Am. J. Med. 163-169.
190. G.H. Stollerman (1975) Rheumatic Fever and Streptococcal Infection New York: Grune & Stratton
191. T. Strasser (1985) Cost-effective control of rheumatic fever in the community. Health Policy 5 159-164.
192. S. Swedo (1994) Sydenham's chorea: A model for childhood autoimmune neuropsychiatric disorders. J. A. M. A. 272 1788-1791.
193. S. Swedo, H. Leonard, et al. (1997) Identification of children with pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections by a marker associated with rheumatic fever. Am. J. Psychiatry 154 110-112.
194. A. Taranta and M. Markowitz (1989) Rheumatic Fever 2nd ed. Boston: Kluwer Academic
195. A. Taranta, M. Spagnuolo, et al. (1962) “Chronic” rheumatic fever. Ann. Intern. Med. 56 367-388.
196. A. Taranta, M. Spagnuolo, et al. (1959) Rheumatic fever in monozygotic and dizygotic twins. Circulation 20 778.
197. K. Taubert, A. Rowley, et al. (1994) Seven-year national survey of Kawasaki disease and acute rheumatic fever. Pediatr. Infect. Dis. J. 13 704-708.
198. M.T. Terreri, S.C. Roja, P.C. Faustino, et al. (2002) Sydenham's chorea—clinical and evolutive characteristics. Sao Paulo Med. J. (Rev. Paulista Med.) 120 16-19.
199. M. Tomai, M. Kotb, et al. (1990) Superantigenicity of streptococcal M protein. J. Exp. Med. 172 359-362.
200. R. Tompkins, D. Burnes, et al. (1977) An analysis of the cost-effectiveness of pharyngitis management and acute rheumatic fever prevention. Ann. Intern. Med. 86 481-492.
201. Y. Uziel, P. Hashkes, et al. (2000) The use of naproxen in the treatment of children with rheumatic fever. J. Pediatr. 137 269-271.
202. G. Veasy (2001) Time to take soundings in acute rheumatic fever. Lancet 357
203. L. Veasy, L. Tani, et al. (1994) Persistence of acute rheumatic fever in the intermountain area of the United States. J. Pediatr. 124 9-16.
204. L. Veasy, S. Wiedmeier, et al. (1987) Resurgence of acute rheumatic fever in the intermountain area of the United States. N. Engl. J. Med. 316 421-427.
205. P. Vendsborg, L. Hansen, et al. (1968) Decreasing incidence of a history of acute rheumatic fever in chronic rheumatic heart disease. Cardiologia 53 332-340.
206. H. Vlajinac, B. Adanja, et al. (1991) Influence of socio-economic and other factors on rheumatic fever occurrence. Eur. J. Epidemiol. 7 702-704.
207. L. Voss, N. Wilson, et al. (2001) Intravenous immunoglobulin in acute rheumatic fever: A randomized controlled trial. Circulation 401-406.
208. E. Wald, B. Dashefsky, et al. (1987) Acute rheumatic fever in western Pennsylvania and the tristate area. Pediatrics 80 371-374.
209. M. Wallace, P. Garst, et al. (1989) The return of acute rheumatic fever in young adults. J. A. M. A. 262 2557-2561.
210. L. Wannamaker (1970) Differences between streptococcal infections of the skin and of the throat. N. Engl. J. Med. 282 23-30. 78-85
211. L. Wannamaker (1982) Virulence factors in streptococci. Scand. J. Infect. Dis. 31(Suppl.), 22-27.
212. L. Wannamaker, F. Denny, et al. (1953) Effect of penicillin prophylaxis on streptococcal disease rates and the carrier state. N. Engl. J. Med. 249 1-7.
213. L. Wannamaker, C. Rammelkamp, et al. (1951) Prophylaxis of acute rheumatic fever: By treatment of the preceding streptococcal infection with various amounts of depot penicillin. Am. J. Med. 10 673-695.
214. R. Westlake, T. Graham, et al. (1990) An outbreak of acute rheumatic fever in Tennessee. Pediatr. Infect. Dis. J. 9 97-100.
215. J.P. Widdowson, W.R. Maxted, et al. (1974) The antibody responses in man to infection with different serotypes of group-A streptococci. J. Med. Microbiol. 7 483-496.
216. E. Wilson, N. Wilson, et al. (2007) Monoarthritis as a major criterion for acute rheumatic fever. Pediatr. Infect. Dis. J.
217. N.J. Wilson and J.M. Neutze (1995) Echocardiographic diagnosis of subclinical carditis in acute rheumatic fever. Int. J. Cardiol. 50 1-6.
218. W. Wilson, K.A. Taubert, M. Gewitz, et al. (2007) Prevention of infective endocarditis: Guidelines from the American Heart Association. Circulation 116 1736-1754.
219. H. Wood, A. Feinstein, et al. (1964) Rheumatic fever in children and adolescents: A long-term epidemiologic study of subsequent prophylaxis, streptococcal infections, and clinical sequelae, III: Comparative effectiveness of three prophylaxis regimens in preventing streptococcal infections and rheumatic recurrences. Ann. Intern. Med. 60(Suppl.), 31-45.
220. H.F. Wood, A.R. Feinstein, et al. (1964) Rheumatic fever in children and adolescents: A long term epidemiologic study of subsequent prophylaxis, streptococcal infections and clinical sequelae, III: Comparative effectiveness of three prophylaxis regimens in preventing streptococcal infections and rheumatic recurrences. Ann. Intern. Med. 60(Suppl. 5), 31-46.
221. World Health Organization (1986) WHO evaluation of the streptozyme test for streptococcal antibodies. Bull. W. H. O. 64 504.
222. World Health Organization: The current evidence for the burden of Group A streptococcal diseases. 60, 2005.
223. J. Zabriskie, D. Lavenchy, et al. (1985) Rheumatic fever-associated B cell alloantigens as identified by monoclonal antibodies. Arthritis Rheum. 28 1047-1051.
224. J.B. Zabriskie (1986) Rheumatic fever: A model for the pathological consequences of microbial-host mimicry. Clin. Exp. Rheumatol. 4 65-73.
225. K. Zangwill, E. Wald, et al. (1991) Acute rheumatic fever in western Pennsylvania: A persistent problem into the 1990s. J. Pediatr. 118 561-563.
226. M. Zedan, F. El-Shennawy, et al. (1992) Interleukin-2 in relation to T cell subpopulations in rheumatic heart disease. Arch. Dis. Child. 67 1373-1375.
227. M.D. Zomorrodi and E.R. Wald (2006) Sydenham's chorea in western Pennsylvania. Pediatrics 117 e675-e679.